Skip to main content

Table 2 The biomarker potential of exosomal ncRNAs in glioma

From: Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications

NcRNA Canditates

Source of exosome

Exosome isolation techniques

System

Biomarker potential

Reference

miR-21

CSF

Ultracentrifugation

GBM

A biomarker for GBM diagnosis

[109]

miR-21

CSF & serum

Ultracentrifugation

Glioma

A biomarker for glioma diagnosis and prognosis

[110]

miR-151a

CSF & serum

Ultracentrifugation

GBM

Predict prognosis of GBM patients

[76]

miR-320 & miR-574-3p

Serum

Precipitation method

GBM

A biomarker for GBM diagnosis

[108]

miR-221

Serum

Precipitation method

Glioma

A biomarker for glioma diagnosis and grade prediction

[62]

miR-21, miR-222 & miR-124-3p

Serum

PEG-based method

Glioma

A biomarker for glioma diagnosis and grade prediction

[104]

miR-301a

Serum

Precipitation method

Glioma

Serve as diagnostic and prognostic biomarker

[105]

miR-148a

Serum

Precipitation method

GBM

A biomarker for GBM diagnosis

[63]

miR-454-3p

Serum

Immunoaffinity capture

Glioma

A biomarker for glioma diagnosis

[106]

lncRNA-HOTAIR

Serum

Precipitation method

GBM

A biomarker for GBM diagnosis

[107]

lncRNA-SBF2-AS1

Serum

Ultracentrifugation

GBM

Serve as diagnostic biomarker for therapy-refractory GBM

[77]

  1. Abbrevations: CSF cerebrospinal fluid, GBM glioblastoma, PEG polyethylene glycol